\-\ Texto\\:\\ \ \(0\)\
\-\ vs\\,\\ cbc\\ \\&\\ cmp\\ wnl\\;\\ no\\ signs\\ of\\ endocrinologic\\ dysfunction\\.\ \(0\)\
\-\ surveillance\\ ct\\ in\\ 6\\-12\\ months\\ given\\ hx\\ of\\ breast\\ cancer\ \(0\)\
\-\ 2\\.6cm\\ x\\ 1\\.9cm\\ left\\ adrenal\\ mass\ \(0\)\
\-\ adrenal\\ adenoma\ \(7\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\\ \\(from\\ her\\ known\\ breast\\ ca\\)\ \(0\)\
\-\ \\â\\€\\¢\\ adrenal\\ adenoma\ \(1\)\
\-\ \\â\\€\\¢\\ pheochromocytoma\ \(2\)\
\-\ \\â\\€\\¢\\ granulomatous\\ disease\ \(0\)\
\-\ \\â\\€\\¢\\ adrenal\\ ganglioneuroma\ \(0\)\
\-\ \\â\\€\\¢\\ adrenal\\ cortical\\ carcinoma\ \(0\)\
\-\ 40\\ y\\.o\\.\\ woman\\ with\\ hx\\ stage\\ iiib\\ breast\\ cancer\\ s\\/p\\ left\\ mastectomy\\ \\&\\ lymph\\ node\\ dissection\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ adrenal\\:\\ 0\\.2963617845365999\ \(0\)\
\-\ breast\\:\\ 0\\.1295571757738583\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.12879570013116887\ \(0\)\
\-\ 2\\.6cm\\:\\ 0\\.12076052635570544\ \(0\)\
\-\ hx\\:\\ 0\\.11590550535057331\ \(0\)\
\-\ endocrinologic\\:\\ 0\\.11126535949871989\ \(0\)\
\-\ adenoma\\:\\ 0\\.09776696854263046\ \(0\)\
\-\ 1\\.9cm\\:\\ 0\\.09621587609230743\ \(0\)\
\-\ 6\\-12\\:\\ 0\\.09410422294398883\ \(0\)\
\-\ iiib\\:\\ 0\\.09227502578474879\ \(0\)\
\-\ ganglioneuroma\\:\\ 0\\.08277985892776324\ \(0\)\
\-\ \\&\\:\\ 0\\.0822298052641488\ \(0\)\
\-\ cancer\\:\\ 0\\.07696343190040453\ \(0\)\
\-\ cmp\\:\\ 0\\.07561207613646807\ \(0\)\
\-\ pheochromocytoma\\:\\ 0\\.07561207613646807\ \(0\)\
\-\ surveillance\\:\\ 0\\.07286316250000023\ \(0\)\
\-\ mastectomy\\:\\ 0\\.0695595726805908\ \(0\)\
\-\ dysfunction\\:\\ 0\\.062367651327742225\ \(0\)\
\-\ wnl\\:\\ 0\\.060064405823605255\ \(0\)\
\-\ dissection\\:\\ 0\\.057539697357879976\ \(0\)\
\-\ granulomatous\\:\\ 0\\.056495486873114446\ \(0\)\
\-\ ca\\:\\ 0\\.05451008927417836\ \(0\)\
\-\ node\\:\\ 0\\.05356498144558998\ \(0\)\
\-\ cbc\\:\\ 0\\.052305563701402505\ \(0\)\
\-\ stage\\:\\ 0\\.049931978478470494\ \(0\)\
\-\ 40\\:\\ 0\\.04924880272449553\ \(0\)\
\-\ s\\/p\\:\\ 0\\.04910150420701248\ \(0\)\
\-\ lymph\\:\\ 0\\.04725400560198146\ \(0\)\
\-\ vs\\:\\ 0\\.04608876671781915\ \(0\)\
\-\ cortical\\:\\ 0\\.04267225822706591\ \(0\)\
\-\ signs\\:\\ 0\\.04119693060254869\ \(0\)\
\-\ given\\:\\ 0\\.04012896428104579\ \(0\)\
\-\ x\\:\\ 0\\.03861734705955448\ \(0\)\
\-\ disease\\:\\ 0\\.03826678195111518\ \(0\)\
\-\ known\\:\\ 0\\.03704179567758657\ \(0\)\
\-\ her\\:\\ 0\\.03519741997924569\ \(0\)\
\-\ y\\.o\\:\\ 0\\.03378601962447534\ \(0\)\
\-\ carcinoma\\:\\ 0\\.03317709137008036\ \(0\)\
\-\ months\\:\\ 0\\.03197179855739818\ \(0\)\
\-\ metastatic\\:\\ 0\\.029467252104330002\ \(0\)\
\-\ \\;\\:\\ 0\\.02774549573222731\ \(0\)\
\-\ woman\\:\\ 0\\.027039766403957617\ \(0\)\
\-\ left\\:\\ 0\\.026194664911586705\ \(0\)\
\-\ from\\:\\ 0\\.017348434426770032\ \(0\)\
\-\ ct\\:\\ 0\\.016374022649206066\ \(0\)\
\-\ mass\\:\\ 0\\.016280287766404992\ \(0\)\
\-\ no\\:\\ 0\\.011786906174024683\ \(0\)\
\-\ \\(\\:\\ 0\\.009895366112929595\ \(0\)\
\-\ \\)\\:\\ 0\\.009774488933058973\ \(0\)\
\-\ in\\:\\ 0\\.005772564796441848\ \(0\)\
\-\ \\,\\:\\ 0\\.003708357061880649\ \(0\)\
\-\ of\\:\\ 0\\.003191884953369546\ \(0\)\
\-\ with\\:\\ 0\\.0016027969327382155\ \(0\)\
\-\ \\.\\:\\ 0\\.0009725900300642814\ \(0\)\
